Acute Myeloid Leukemia study

Machine Learning Model to predict survival in AML patients

Developed by: Steve Tungjitviboonkun, MD, MS
Department of Epidemiology & Biostatistics, University of California San Francisco

This tool is currently under validation and is intended for research and demonstration purposes only.

About the Patient

Must be between 18 and 88 years.
A risk category from lab and genetic testing that shows how the leukemia is expected to respond to treatment: Favorable is the best outlook, Adverse is the most difficult. Your doctor's report will state this.
Test called karyotyping. "Normal" means no major chromosome changes were found. "Complex" means several chromosome abnormalities were found.
Genetic Mutation Test Results

From blood or bone marrow sample

Results will appear after prediction.

Survival prediction

Time % probability of survival
6 months—
12 months—
18 months—
24 months—